NovoCure Ownership | Who Owns NovoCure?
NovoCure Ownership Summary
NovoCure is owned by 81.75% institutional investors, 9.64% insiders, and 8.61% retail investors. Fmr is the largest institutional shareholder, holding 14.99% of NVCR shares. American Funds SMALLCAP World A is the top mutual fund, with 7.34% of its assets in NovoCure shares.
NVCR Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | NovoCure | 81.75% | 9.64% | 8.61% |
Sector | Healthcare Stocks | 56.95% | 9.28% | 33.77% |
Industry | Medical Instruments & Supplies Stocks | 45.87% | 12.68% | 41.45% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 16.23M | 14.99% | $483.66M |
Blackrock funding, inc. /de | 13.03M | 12.03% | $388.19M |
Blackrock | 12.13M | 11.31% | $207.83M |
Vanguard group | 11.80M | 10.90% | $351.52M |
Capital investors | 8.87M | 8.20% | $264.44M |
Capital world investors | 4.82M | 4.45% | $143.50M |
State street | 3.01M | 2.80% | $51.49M |
Soleus capital management | 2.74M | 2.53% | $81.64M |
Geode capital management | 2.40M | 2.22% | $71.54M |
T. rowe price investment management | 1.69M | 1.56% | $50.38M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Superstring capital management lp | 286.97K | 7.41% | $8.55M |
Invus financial advisors | 350.88K | 6.74% | $6.01M |
Soleus capital management | 2.74M | 5.13% | $81.64M |
Nordwand advisors | 312.15K | 3.83% | $9.30M |
Palo alto investors lp | 814.19K | 3.76% | $24.26M |
Taylor frigon capital management | 143.44K | 2.16% | $4.27M |
Granite investment partners | 686.73K | 0.88% | $20.46M |
Birchview capital, lp | 31.00K | 0.75% | $923.80K |
Essex investment management | 121.83K | 0.65% | $3.63M |
Emerald advisers | 547.56K | 0.63% | $16.32M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 12.13M | 0.00% | 3.05M |
Soleus capital management | 2.74M | 5.13% | 2.74M |
Capital investors | 8.87M | 0.05% | 951.14K |
Granite investment partners | 686.73K | 0.88% | 686.73K |
Emerald advisers | 547.56K | 0.63% | 547.56K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Nordwand advisors | 312.15K | 3.83% | -2.72M |
T. rowe price investment management | 1.69M | 0.03% | -1.12M |
Morgan stanley | 806.52K | 0.00% | -950.12K |
Price t rowe associates inc /md/ | 1.68M | 0.01% | -638.38K |
Marshall wace, llp | 270.95K | 0.01% | -508.72K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Granite investment partners | 686.73K | 0.88% | 686.73K | $20.46M |
Emerald advisers | 547.56K | 0.63% | 547.56K | $16.32M |
Silvercrest asset management group | 385.41K | 0.05% | 385.41K | $6.60M |
Emerald mutual fund advisers trust | 325.25K | 0.59% | 325.25K | $9.69M |
Adage capital partners gp | 200.00K | 0.01% | 200.00K | $5.96M |
Sold Out
Holder | Change |
---|---|
Salem investment counselors | -4.00 |
Mather group, llc. | -15.00 |
Central trust | -18.00 |
Raleigh capital management | -26.00 |
Rise advisors | -30.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 249 | 5.51% | 88,494,339 | -4.72% | 81 | 1.11% | 117 | 27.17% | 74 | - |
Sep 30, 2024 | 234 | -6.02% | 92,882,050 | -0.04% | 85 | 1.14% | 91 | -26.61% | 73 | 7.35% |
Jun 30, 2024 | 247 | -4.26% | 92,913,219 | 4.09% | 86 | 1.23% | 123 | -1.60% | 67 | 6.35% |
Mar 31, 2024 | 258 | 7.05% | 89,258,298 | -1.39% | 83 | 1.17% | 125 | -2.34% | 63 | 12.50% |
Dec 31, 2023 | 241 | -5.12% | 90,513,161 | -0.77% | 84 | 1.15% | 128 | 5.79% | 56 | -11.11% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
American Funds SMALLCAP World A | 7.94M | 7.34% | 1.42M |
Fidelity Growth Compy Commingled Pl S | 7.65M | 7.07% | 74.37K |
Fidelity Growth Compy Commingled Pl O | 7.46M | 6.89% | - |
Fidelity Growth Company Fund | 5.25M | 4.85% | -38.51K |
Vanguard Total Stock Mkt Idx Inv | 3.39M | 3.13% | 3.53K |
American Funds Growth Fund of Amer A | 3.30M | 3.05% | - |
Capital Group Growth Fnd of Amer Comp | 3.30M | 3.05% | - |
BioPharma Credit Ord | 2.92M | 2.70% | 2.92M |
iShares Russell 2000 ETF | 2.89M | 2.67% | -21.95K |
Vanguard Small Cap Index | 2.76M | 2.55% | 21.33K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 11, 2025 | Paravasthu Mukund | Chief Operating Officer | Sell | $57.91K |
Nov 02, 2024 | Paravasthu Mukund | Chief Operating Officer | Sell | $734.18 |
Oct 31, 2024 | Puri Michal Nath | Chief Human Resources Officer | Sell | $12.79K |
Nov 01, 2024 | Leonard Frank X | EVP, Pres., Novocure Oncology | Sell | $9.53K |
Nov 01, 2024 | Paravasthu Mukund | Chief Operating Officer | Sell | $2.54K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | - | 4 |
2024 Q3 | - | 1 |
2024 Q2 | - | 3 |
2024 Q1 | - | 6 |
NVCR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools